Superworth

Viatris profit margin VTRS

Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.

Net margin, 12 months
−2.8%
Operating margin, 12 months
−0.6%
Net margin on a year earlier
+21.8 pts
Peer median
11.8%

Over the twelve months to Jun 30, 2026, Viatris kept −2.8% of its revenue as net profit, with an operating margin of −0.6% and a gross margin of 34.8%.

Five years earlier its net margin was −13.1%.

The median for 10 healthcare stocks of a similar size is 11.8%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−24.6%−18.6%35.1%
FY2024−4.3%0.1%38.2%
FY20230.4%5.0%41.7%
FY202212.8%9.9%40.0%
FY2021−7.1%−0.2%31.2%
FY2020−5.6%−1.8%31.8%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−2.8%+21.8 pts−0.6%
Q1 FY26−2.0%+24.4 pts1.0%
Q4 FY25−24.6%−20.3 pts−18.6%
Q3 FY25−26.1%−20.3 pts−18.8%
Q2 FY25−24.6%−20.3 pts−18.4%
Q1 FY25−26.4%−26.1 pts−21.5%
Q4 FY24−4.3%−4.7 pts0.1%
Q3 FY24−5.9%−17.7 pts−1.8%
Q2 FY24−4.2%−16.1 pts−0.3%
Q1 FY24−0.4%−12.4 pts3.7%
Q4 FY230.4%−12.4 pts5.0%
Q3 FY2311.8%+7.0 pts6.6%

Against its peers

Companies in Healthcare nearest Viatris' size, closest first, today.

CompanyProfit margin
VTRSViatris−2.8%
THCTenet Healthcare10.3%
STESTERIS13.3%
ZBHZimmer Biomet9.5%
MEDPMedpace17.7%
INCYIncyte27.7%
RVTYRevvity8.2%
UTHRUnited Therapeutics41.6%
LHLabcorp7.0%
DGXQuest Diagnostics9.2%
EXELExelixis35.3%
Peer median11.8%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Viatris

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.